Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
ADvantage Therapeutics Logo
ADvantage Therapeutics Growth Score
61
CB Rank
47171
Heat Score
41
ADvantage Therapeutics develops therapies to treat neurodegenerative conditions focusing on Alzheimer’s Disease.
Founded
obfuscation
PrivateGrant Miami, Florida, United States11-50 advantagetherapeutics.com/
Biopharma
Biotechnology
Health Care
Medical
Overview

ADvantage Therapeutics
Total Funding
obfuscation
Growth Score
61
Heat Score
41

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score61
-5 pts
in past quarter
Heat Score 41
-4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About ADvantage Therapeutics

CB Rank
47171
ADvantage Therapeutics develops therapies to treat neurodegenerative conditions focusing on Alzheimer’s Disease.
Founded
obfuscation
PrivateGrant Miami, Florida, United States11-50 advantagetherapeutics.com/
Biopharma
Biotechnology
Health Care
Medical

Funding Rounds

Grant
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name ADvantage Therapeutics, Inc.
Operating Status Active
Company Type For Profit
Founders  Agustin Fernandez III, Jeffrey Madden
About the Company
ADvantage Therapeutics is a pharmaceutical company that develops therapeutics for patients suffering from neurodegenerative disease. It specializes in developing therapies to treat Alzheimer's Disease and potentially paradigm-changing therapies.
Phone Number 305-846-9027
Predictions & Insights

Growth Insight

See this Growth Insight
ADvantage Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

AD04™
A subcutaneous injectable immunomodulator developed for treating early-stage Alzheimer's Disease by slowing cognitive decline and hippocampal atrophy.
Klotho-based Therapies (via Klothea Bio)
mRNA-based therapies designed to increase Klotho protein levels to address age-related diseases and promote healthy aging.

Research & Development

ADvantage Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - ADvantage Therapeutics Logo
Grant - ADvantage Therapeutics
1
obfuscation
National Institute on AgingGrant
obfuscation
Grant - ADvantage Therapeutics Logo
Grant - ADvantage Therapeutics
1
obfuscation
National Institute on AgingGrant
obfuscation
Grant - ADvantage Therapeutics Logo
Grant - ADvantage Therapeutics
1
obfuscation
National Institute on AgingGrant
obfuscation
Grant - ADvantage Therapeutics Logo
Grant - ADvantage Therapeutics
1
obfuscation
National Institute on AgingGrant
obfuscation
Grant - ADvantage Therapeutics Logo
Grant - ADvantage Therapeutics
1
obfuscation
National Institute on AgingGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - ADvantage Therapeutics Logo
Grant - ADvantage Therapeutics
1
obfuscation
National Institute on AgingGrant
obfuscation
Grant - ADvantage Therapeutics Logo
Grant - ADvantage Therapeutics
1
obfuscation
National Institute on AgingGrant
obfuscation
Grant - ADvantage Therapeutics Logo
Grant - ADvantage Therapeutics
1
obfuscation
National Institute on AgingGrant
obfuscation
Grant - ADvantage Therapeutics Logo
Grant - ADvantage Therapeutics
1
obfuscation
National Institute on AgingGrant
obfuscation
Grant - ADvantage Therapeutics Logo
Grant - ADvantage Therapeutics
1
obfuscation
National Institute on AgingGrant

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 6 Board Members and Advisors 1 Contacts 5

Employee Profiles

Board Members and Advisors

News

News and Press

News•Oct 9, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 29, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 29, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 29, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

640
7.74%
 in past month

Active Website Tech Count

2ADvantage Therapeutics is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 5m.
Sub-Organizations

Sub-Organizations

Number of Sub-Orgs 1
Which industries do these Sub-Organization operate in?
Klothea Bio Logo
Klothea BioSubsidiary
Frequently Asked Questions

Where is ADvantage Therapeutics's headquarters? ADvantage Therapeutics is located in Miami, Florida, United States.Who invested in ADvantage Therapeutics? ADvantage Therapeutics is funded by National Institute on Aging.When was the last funding round for ADvantage Therapeutics? ADvantage Therapeutics closed its last funding round on
obfuscation
from a Grant round.Who are ADvantage Therapeutics's competitors? Alternatives and possible competitors to ADvantage Therapeutics may include Eli Lilly, Cognition Therapeutics, and  India Globalization Capital.How much funding has ADvantage Therapeutics raised to date? ADvantage Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(bc80b4a 1)
|